We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 53,477

Life sciences: product regulation and liability in the USA
  • Perkins Coie LLP
  • Global, USA
  • February 24 2017

A structured guide to product regulation and liability in the USA


NAD shoots down Bowflex’s claims of dramatic weight loss as unsupported; disclaimer not enough
  • Porter Wright Morris & Arthur LLP
  • USA
  • February 24 2017

Nautilus’s Bowflex TreadClimber just became the latest example of enforcement action against a health and fitness product by the National Advertising


Fourth Circuit Leaves Undisturbed a District Court Decision Against the Use of Statistical Sampling, and Holds that the United States Has the Unfettered Power to Veto FCA Settlements
  • Drinker Biddle & Reath LLP
  • USA
  • February 24 2017

The Fourth Circuit recently decided an interlocutory appeal raising important issues arising under the False Claims Act (FCA). See United States ex


Medicaid Financing Reform: Per Capita Caps vs. Block Grants
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • February 24 2017

In the coming weeks, it is highly likely that House Republicans will come forward with Medicaid financing reform proposals, such as block grant or a


Clinical trials in the USA
  • Perkins Coie LLP
  • Global, USA
  • February 24 2017

A structured guide to clinical trials in the USA


Life Sciences: Compliance and enforcement in the USA
  • Perkins Coie LLP
  • USA
  • February 24 2017

A structured guide to compliance and dishonest practices in the USA


Pharmacovigilance in the USA
  • Perkins Coie LLP
  • USA
  • February 24 2017

A structured guide to Pharmacovigilance in the USA


The State AG Report Weekly Update February 23, 2017
  • Cozen O'Connor
  • USA
  • February 23 2017

Oklahoma Governor Mary Fallin appointed Secretary of State Mike Hunter as Oklahoma AG to succeed former AG Scott Pruitt, who was confirmed as EPA


Editing the future: A brief introduction to CRISPR
  • Allen & Overy LLP
  • USA
  • February 23 2017

For those with an interest in life sciences, the rise to prominence of CRISPR has been impossible to ignore. It seems a day does not go by without


Matching Claim Language with Label Language Ensnares Infringers
  • Knobbe Martens Olson & Bear LLP
  • USA
  • February 23 2017

On January 12, 2017, the U.S. Court of Appeals for the Federal Circuit issued an opinion affirming the judgement that Eli Lilly’s U.S. Patent No. 7